Authors:
Sokolovskaya, AA
Zabotina, TN
Blokhin, DY
Inshakov, AN
Mikhailov, AD
Kadagidze, ZG
Baryshnikov, AY
Citation: Aa. Sokolovskaya et al., CD95-deficient cells of Jurkat/A4 subline are resistant to drug-induced apoptosis, EXP ONCOL, 23(3), 2001, pp. 175-180
Authors:
Sokolovskaya, AA
Zabotina, TN
Blokhin, DY
Kadagidze, ZG
Baryshnikov, AY
Citation: Aa. Sokolovskaya et al., Comparative analysis of apoptosis induced by various anticancer drugs in Jurkat cells, EXP ONCOL, 23(1), 2001, pp. 46-50
Authors:
Polosukhina, ER
Baryshnikov, AY
Shishkin, YV
Zabotina, TN
Logacheva, NP
Tupitsyn, NN
Volkova, MA
Turkina, AG
Tsvetaeva, NV
Golenkov, AK
Shirin, AD
Kataeva, EV
Trifonova, EV
Mitina, TA
Mikhailova, IN
Lysyuk, EY
Mayakova, SA
Kadagidze, ZG
Citation: Er. Polosukhina et al., Expression of antigen CD95(Fas/APO-1) mediating apoptosis in hemoblastosesusing monoclonal antibodies ICO-160., GEMATOL TR, 45(4), 2000, pp. 3-6
Authors:
Baryshnikov, AY
Polosukhina, ER
Shishkin, YV
Tupitsyn, NN
Syrkin, AB
Gavrikova, NV
Andreeva, LY
Zabotina, TN
Mayakova, SA
Kurmashev, VI
Kadagidze, ZG
Citation: Ay. Baryshnikov et al., A new prognostic marker of acute lymphoblastic leukemia - antigen CD95(Fas/APO-1)., GEMATOL TR, 43(2), 1998, pp. 8-11